Synthesis and anti-staphylococcal activity of novel bacterial topoisomerase inhibitors with a 5-amino-1,3-dioxane linker moiety.
Bioorg Med Chem Lett
; 28(14): 2477-2480, 2018 08 01.
Article
in En
| MEDLINE
| ID: mdl-29871847
ABSTRACT
Novel bacterial type II topoisomerase inhibitors (NBTIs) constitute a promising new class of antibacterial agents. We report a series of NBTIs with potent anti-staphylococcal activity and diminished hERG inhibition. Dioxane-linked compound 9 demonstrated MICs ≤1⯵g/mL against both methicillin-susceptible (MSSA) and -resistant Staphylococcus aureus (MRSA), accompanied by reduced hERG inhibition as compared to cyclohexane- or piperidine-linked analogs.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Quinolines
/
DNA Topoisomerases, Type II
/
Potassium Channel Blockers
/
Dioxanes
/
Methicillin-Resistant Staphylococcus aureus
/
Topoisomerase II Inhibitors
/
Anti-Bacterial Agents
Limits:
Humans
Language:
En
Journal:
Bioorg Med Chem Lett
Journal subject:
BIOQUIMICA
/
QUIMICA
Year:
2018
Document type:
Article
Affiliation country:
Estados Unidos